EC
LIF

Elequin Capital’s Life360 LIF Stock Holding History

Elequin Capital’s Portfolio LIF Stock Details LIF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$449 Sell
11
-5
-31% -$259 ﹤0.01% 583
2025
Q4 		$1.03K Buy
+16
New +$1.33K ﹤0.01% 375

Other funds holding LIF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Elequin Capital's LIF Position: Q1 2026 in Review

Elequin Capital reduced its Life360 (LIF) stake by 31% in Q1 2026, selling an estimated $259 and leaving 11 shares worth $449. The position accounts for ﹤0.01% of the portfolio, ranked #583.

Elequin Capital first reported a position in LIF in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.03K in Q4 2025. 193 funds tracked by Wall St. Rank hold LIF as of Q1 2026.

  • Elequin Capital held 11 shares of Life360 worth $449 as of Q1 2026.
  • Elequin Capital sold 5 Life360 shares in Q1 2026, an estimated $259.
  • Life360 made up ﹤0.01% of Elequin Capital's portfolio in Q1 2026, its #583 holding.
  • Elequin Capital first reported a position in Life360 in Q4 2025 and has held it in 2 quarters since.
  • Elequin Capital's Life360 position peaked at $1.03K in Q4 2025.
  • 193 funds tracked by Wall St. Rank held Life360 as of Q1 2026.

Based on Elequin Capital's 13F filing for Q1 2026, filed 11 May 2026.